BioGaia AB (publ) Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 26 Fair Values set on narratives written by author
BIOG B Community Narratives
Expanding North American Demand Will Unlock New Health Trends
Expanding North American Demand Will Unlock New Health Trends
View narrativeTrending Discussion
No trending discussion available.
Recently Updated Narratives
BIOG B: Dividend Power And Skincare Expansion Will Support Future Rerating
Snowflake Analysis
BioGaia AB (publ) Key Details
- 3.43
- 73.01%
- 21.97%
- 0%
About BIOG B
- Founded
- 1990
- Employees
- 251
- CEO
- Website
View website
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. Its Adult Health segment provides gut health tablets, bone health tablets, and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment offers packaging solutions. It sells its products through distribution partners or through its own distribution channels. The company was incorporated in 1990 and is headquartered in Stockholm, Sweden.